Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb EBITDA 2010-2024 | BMY

Bristol Myers Squibb annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Bristol Myers Squibb EBITDA for the quarter ending September 30, 2024 was $4.268B, a 6.65% decline year-over-year.
  • Bristol Myers Squibb EBITDA for the twelve months ending September 30, 2024 was $3.304B, a 82.08% decline year-over-year.
  • Bristol Myers Squibb 2023 annual EBITDA was $18.2B, a 1.17% increase from 2022.
  • Bristol Myers Squibb 2022 annual EBITDA was $17.989B, a 4.23% decline from 2021.
  • Bristol Myers Squibb 2021 annual EBITDA was $18.784B, a 435.31% increase from 2020.
  
Bristol Myers Squibb Annual EBITDA
(Millions of US $)
2023 $18,200
2022 $17,989
2021 $18,784
2020 $3,509
2019 $6,721
2018 $6,605
2017 $5,920
2016 $6,297
2015 $2,453
2014 $2,848
2013 $3,654
2012 $5,143
2011 $7,609
2010 $6,678
2009 $6,027
Bristol Myers Squibb Quarterly EBITDA
(Millions of US $)
2024-09-30 $4,268
2024-06-30 $3,882
2024-03-31 $-8,984
2023-12-31 $4,138
2023-09-30 $4,572
2023-06-30 $4,291
2023-03-31 $5,199
2022-12-31 $4,380
2022-09-30 $4,797
2022-06-30 $4,541
2022-03-31 $4,271
2021-12-31 $4,437
2021-09-30 $4,884
2021-06-30 $4,265
2021-03-31 $5,198
2020-12-31 $-7,761
2020-09-30 $4,912
2020-06-30 $4,185
2020-03-31 $2,173
2019-12-31 $1,107
2019-09-30 $1,520
2019-06-30 $1,945
2019-03-31 $2,149
2018-12-31 $1,677
2018-09-30 $2,332
2018-06-30 $674
2018-03-31 $1,922
2017-12-31 $895
2017-09-30 $1,371
2017-06-30 $1,506
2017-03-31 $2,148
2016-12-31 $1,208
2016-09-30 $1,664
2016-06-30 $1,705
2016-03-31 $1,720
2015-12-31 $-334
2015-09-30 $1,092
2015-06-30 $143
2015-03-31 $1,552
2014-12-31 $43
2014-09-30 $1,120
2014-06-30 $483
2014-03-31 $1,202
2013-12-31 $1,050
2013-09-30 $998
2013-06-30 $719
2013-03-31 $887
2012-12-31 $1,004
2012-09-30 $766
2012-06-30 $1,207
2012-03-31 $2,166
2011-12-31 $1,863
2011-09-30 $1,853
2011-06-30 $1,974
2011-03-31 $1,919
2010-12-31 $1,654
2010-09-30 $1,749
2010-06-30 $1,722
2010-03-31 $1,553
2009-12-31 $1,434
2009-09-30 $1,658
2009-06-30 $1,596
2009-03-31 $1,339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $115.180B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.371B 13.49
Gilead Sciences (GILD) United States $114.507B 20.74
Vertex Pharmaceuticals (VRTX) United States $104.495B 0.00
CSL (CSLLY) Australia $84.407B 0.00
Regeneron Pharmaceuticals (REGN) United States $78.592B 17.89
GSK (GSK) United Kingdom $70.363B 8.14
Argenex SE (ARGX) Netherlands $37.438B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.133B 0.00
BioNTech SE (BNTX) Germany $27.642B 0.00
Biogen (BIIB) United States $21.858B 9.39
Illumina (ILMN) United States $20.766B 75.68
BeiGene (ONC) Cayman Islands $17.962B 0.00
Moderna (MRNA) United States $16.162B 0.00
Genmab (GMAB) Denmark $13.897B 20.39
Incyte (INCY) United States $13.395B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.672B 29.42
Insmed (INSM) United States $12.514B 0.00
Sarepta Therapeutics (SRPT) United States $11.853B 106.97
Bio-Techne Corp (TECH) United States $11.358B 43.85
Exact Sciences (EXAS) United States $10.535B 0.00
Vaxcyte (PCVX) United States $10.382B 0.00
QIAGEN (QGEN) Netherlands $10.160B 20.90
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Exelixis (EXEL) United States $9.693B 22.04
Bio-Rad Laboratories (BIO.B) United States $9.116B 30.98
Intra-Cellular Therapies (ITCI) United States $8.931B 0.00
Roivant Sciences (ROIV) United Kingdom $8.794B 0.00
Ascendis Pharma (ASND) Denmark $8.374B 0.00
Repligen (RGEN) United States $8.015B 104.42
Jazz Pharmaceuticals (JAZZ) Ireland $7.482B 7.32
Revolution Medicines (RVMD) United States $7.402B 0.00
Legend Biotech (LEGN) United States $6.343B 0.00
Halozyme Therapeutics (HALO) United States $6.108B 13.80
Cytokinetics (CYTK) United States $5.774B 0.00
Nuvalent (NUVL) United States $5.683B 0.00
Blueprint Medicines (BPMC) United States $5.539B 0.00
Telix Pharmaceuticals (TLX) Australia $5.021B 0.00
TG Therapeutics (TGTX) United States $4.835B 0.00
Alkermes (ALKS) Ireland $4.652B 15.62
Viking Therapeutics (VKTX) United States $4.582B 0.00
Krystal Biotech (KRYS) United States $4.501B 74.52
Arcellx (ACLX) United States $4.258B 0.00
ADMA Biologics Inc (ADMA) United States $4.248B 44.92
Axsome Therapeutics (AXSM) United States $4.232B 0.00
Scholar Rock Holding (SRRK) United States $4.134B 0.00
Apellis Pharmaceuticals (APLS) United States $4.125B 0.00
Alvotech (ALVO) Luxembourg $3.968B 0.00
Guardant Health (GH) United States $3.925B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.916B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.800B 0.00
Biohaven (BHVN) United States $3.770B 0.00
Avidity Biosciences (RNA) United States $3.720B 0.00
Immunovant (IMVT) United States $3.698B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.692B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.536B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.423B 0.00
NovoCure (NVCR) Jersey $3.245B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.105B 23.92
Xenon Pharmaceuticals (XENE) Canada $3.063B 0.00
Denali Therapeutics (DNLI) United States $2.999B 0.00
Merus (MRUS) Netherlands $2.896B 0.00
Janux Therapeutics (JANX) United States $2.794B 0.00
Amicus Therapeutics (FOLD) United States $2.782B 0.00
Vericel (VCEL) United States $2.720B 918.50
Zai Lab (ZLAB) China $2.715B 0.00
Twist Bioscience (TWST) United States $2.689B 0.00
SpringWorks Therapeutics (SWTX) United States $2.684B 0.00
Vera Therapeutics (VERA) United States $2.672B 0.00
Kymera Therapeutics (KYMR) United States $2.648B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.629B 0.00
Edgewise Therapeutics (EWTX) United States $2.559B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.445B 0.00
Iovance Biotherapeutics (IOVA) United States $2.374B 0.00
Mesoblast (MESO) Australia $2.353B 0.00
Protagonist Therapeutics (PTGX) United States $2.323B 14.65
CG Oncology (CGON) United States $2.203B 0.00
Geron (GERN) United States $2.176B 0.00
IDEAYA Biosciences (IDYA) United States $2.175B 0.00
Bavarian Nordic (BVNRY) Denmark $2.136B 13.09
Apogee Therapeutics (APGE) United States $2.123B 0.00
NeoGenomics (NEO) United States $2.117B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.108B 0.00
Ligand Pharmaceuticals (LGND) United States $2.049B 51.14
Beam Therapeutics (BEAM) United States $2.045B 0.00
WAVE Life Sciences (WVE) Singapore $2.031B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.018B 0.00
Belite Bio (BLTE) United States $2.000B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.986B 16.51
Akero Therapeutics (AKRO) United States $1.960B 0.00
Disc Medicine (IRON) United States $1.858B 0.00
Galapagos (GLPG) Belgium $1.838B 0.00
MannKind (MNKD) United States $1.820B 47.14
Agios Pharmaceuticals (AGIO) United States $1.816B 0.00
ImmunityBio (IBRX) United States $1.791B 0.00
Certara (CERT) United States $1.716B 48.46
Celldex Therapeutics (CLDX) United States $1.711B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.704B 0.00
Dynavax Technologies (DVAX) United States $1.696B 99.23
Fortrea Holdings (FTRE) United States $1.673B 53.29
Structure Therapeutics (GPCR) United States $1.614B 0.00
Viridian Therapeutics (VRDN) United States $1.565B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.492B 0.00
Praxis Precision Medicines (PRAX) United States $1.482B 0.00
Travere Therapeutics (TVTX) United States $1.481B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.440B 0.00
Arcus Biosciences (RCUS) United States $1.385B 0.00
Nurix Therapeutics (NRIX) United States $1.382B 0.00
Novavax (NVAX) United States $1.373B 0.00
MiMedx (MDXG) United States $1.364B 35.69
Arvinas (ARVN) United States $1.298B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.282B 0.00
Intellia Therapeutics (NTLA) United States $1.245B 0.00
Myriad Genetics (MYGN) United States $1.229B 0.00
Spyre Therapeutics (SYRE) United States $1.227B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.202B 0.00
ANI Pharmaceuticals (ANIP) United States $1.166B 15.89
Rocket Pharmaceuticals (RCKT) United States $1.160B 0.00
Gyre Therapeutics (GYRE) United States $1.122B 0.00
Anavex Life Sciences (AVXL) United States $1.031B 0.00
Liquidia Technologies (LQDA) United States $1.024B 0.00
Zymeworks (ZYME) United States $1.018B 0.00
Vir Biotechnology (VIR) United States $1.001B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.992B 0.00
Septerna (SEPN) United States $0.948B 0.00
ArriVent BioPharma (AVBP) United States $0.926B 0.00
Bicara Therapeutics (BCAX) United States $0.921B 0.00
Poseida Therapeutics (PSTX) United States $0.919B 0.00
Adaptive Biotechnologies (ADPT) United States $0.914B 0.00
AbCellera Biologics (ABCL) Canada $0.895B 0.00
Immatics (IMTX) Germany $0.886B 0.00
UniQure (QURE) Netherlands $0.880B 0.00
Upstream Bio (UPB) United States $0.874B 0.00
Nuvation Bio (NUVB) United States $0.872B 0.00
Cogent Biosciences (COGT) United States $0.862B 0.00
Replimune (REPL) United States $0.859B 0.00
89BIO (ETNB) United States $0.847B 0.00
Pacira BioSciences (PCRX) United States $0.846B 7.97
Cytek Biosciences (CTKB) United States $0.846B 0.00
Pliant Therapeutics (PLRX) United States $0.808B 0.00
Avid Bioservices (CDMO) United States $0.788B 0.00
Castle Biosciences (CSTL) United States $0.785B 140.20
LENZ Therapeutics (LENZ) United States $0.778B 0.00
CureVac (CVAC) Germany $0.772B 6.27
Erasca (ERAS) United States $0.763B 0.00
Prothena (PRTA) Ireland $0.736B 0.00
Tyra Biosciences (TYRA) United States $0.730B 0.00
Cullinan Therapeutics (CGEM) United States $0.721B 0.00
Pharming Group (PHAR) Netherlands $0.710B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.700B 0.00
CARGO Therapeutics (CRGX) United States $0.693B 0.00
Dianthus Therapeutics (DNTH) United States $0.687B 0.00
Oculis Holding AG (OCS) Switzerland $0.686B 0.00
Kura Oncology (KURA) United States $0.675B 0.00
Tectonic Therapeutic (TECX) United States $0.674B 0.00
Rapport Therapeutics (RAPP) United States $0.673B 0.00
Immunome (IMNM) United States $0.657B 0.00
Entrada Therapeutics (TRDA) United States $0.653B 10.98
Humacyte (HUMA) United States $0.652B 0.00
Keros Therapeutics (KROS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.623B 0.00
MBX Biosciences (MBX) United States $0.610B 0.00
Mineralys Therapeutics (MLYS) United States $0.610B 0.00
GRAIL (GRAL) United States $0.602B 0.00
Stoke Therapeutics (STOK) United States $0.597B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.587B 0.00
Annexon (ANNX) United States $0.586B 0.00
Oric Pharmaceuticals (ORIC) United States $0.583B 0.00
Emergent Biosolutions (EBS) United States $0.556B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.553B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.548B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.531B 0.00
Astria Therapeutics (ATXS) United States $0.506B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.501B 0.00
CorMedix Inc (CRMD) United States $0.499B 0.00
Third Harmonic Bio (THRD) United States $0.497B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Celcuity (CELC) United States $0.488B 0.00
Terns Pharmaceuticals (TERN) United States $0.482B 0.00
PureTech Health (PRTC) United States $0.466B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.462B 0.00
Abivax SA (ABVX) France $0.462B 0.00
Allogene Therapeutics (ALLO) United States $0.461B 0.00
Kodiak Sciences (KOD) United States $0.454B 0.00
Alpha Teknova (TKNO) United States $0.444B 0.00
MaxCyte (MXCT) United States $0.439B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.437B 0.00
Cartesian Therapeutics (RNAC) United States $0.430B 0.00
ChromaDex (CDXC) United States $0.419B 548.00
Aura Biosciences (AURA) United States $0.413B 0.00
GH Research (GHRS) Ireland $0.412B 0.00
Codexis (CDXS) United States $0.407B 0.00
AnaptysBio (ANAB) United States $0.407B 0.00
Prime Medicine (PRME) United States $0.392B 0.00
REGENXBIO (RGNX) United States $0.389B 0.00
Alumis (ALMS) United States $0.388B 0.00
Zenas BioPharma (ZBIO) United States $0.377B 0.00
Contineum Therapeutics (CTNM) United States $0.373B 0.00
Eton Pharmaceuticals (ETON) United States $0.373B 0.00
IGM Biosciences (IGMS) United States $0.369B 0.00
Sana Biotechnology (SANA) United States $0.368B 0.00
Kamada (KMDA) Israel $0.364B 22.61
Northwest Biotherapeutics (NWBO) United States $0.363B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.357B 0.00
Sage Therapeutics (SAGE) United States $0.354B 0.00
Design Therapeutics (DSGN) United States $0.349B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.349B 0.00
Neurogene (NGNE) United States $0.340B 0.00
Tango Therapeutics (TNGX) United States $0.336B 0.00
Trevi Therapeutics (TRVI) United States $0.335B 0.00
ACELYRIN, INC (SLRN) United States $0.331B 0.00
ATyr Pharma (ATYR) United States $0.328B 0.00
Voyager Therapeutics (VYGR) United States $0.326B 8.41
Prima BioMed (IMMP) Australia $0.322B 0.00
Revance Therapeutics (RVNC) United States $0.319B 0.00
Olema Pharmaceuticals (OLMA) United States $0.319B 0.00
Neumora Therapeutics (NMRA) United States $0.318B 0.00
Jasper Therapeutics (JSPR) United States $0.316B 0.00
Precigen (PGEN) United States $0.316B 0.00
EnGene Holdings (ENGN) Canada $0.312B 0.00
Absci (ABSI) United States $0.311B 0.00
XOMA Royalty (XOMA) United States $0.306B 0.00
Chimerix (CMRX) United States $0.305B 0.00
Rezolute (RZLT) United States $0.298B 0.00
Candel Therapeutics (CADL) United States $0.292B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Verastem (VSTM) United States $0.289B 0.00
ITeos Therapeutics (ITOS) United States $0.289B 0.00
AC Immune (ACIU) Switzerland $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.281B 0.00
Benitec Biopharma (BNTC) United States $0.280B 0.00
Ocugen (OCGN) United States $0.262B 0.00
Fulcrum Therapeutics (FULC) United States $0.261B 0.00
C4 Therapeutics (CCCC) United States $0.258B 0.00
Abeona Therapeutics (ABEO) United States $0.257B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.256B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Urogen Pharma (URGN) United States $0.251B 0.00
Lifecore Biomedical (LFCR) United States $0.245B 0.00
Artiva Biotherapeutics (ARTV) United States $0.242B 0.00
Anika Therapeutics (ANIK) United States $0.237B 0.00
BioStem Technologies (BSEM) $0.237B 20.90
Sangamo Therapeutics (SGMO) United States $0.236B 0.00
DiaMedica Therapeutics (DMAC) United States $0.236B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Inhibrx Biosciences (INBX) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.220B 0.00
Cardiff Oncology (CRDF) United States $0.218B 0.00
Opthea (OPT) Australia $0.215B 0.00
Amarin (AMRN) Ireland $0.215B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.214B 0.00
Nautilus Biotechnology (NAUT) United States $0.212B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.205B 0.00
Fate Therapeutics (FATE) United States $0.204B 0.00
BioAge Labs (BIOA) United States $0.199B 0.00
Molecular Partners AG (MOLN) Switzerland $0.197B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.193B 0.00
Compass Therapeutics (CMPX) United States $0.193B 0.00
Cidara Therapeutics (CDTX) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.191B 0.00
Semper Paratus Acquisition (TVGN) United States $0.186B 0.00
Alector (ALEC) United States $0.185B 0.00
Inozyme Pharma (INZY) United States $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.182B 0.00
ScPharmaceuticals (SCPH) United States $0.179B 0.00
Nkarta (NKTX) United States $0.176B 0.00
TuHURA Biosciences (HURA) United States $0.174B 0.00
Mersana Therapeutics (MRSN) United States $0.173B 0.00
Adherex Technologies (FENC) United States $0.173B 0.00
Kyverna Therapeutics (KYTX) United States $0.169B 0.00
TScan Therapeutics (TCRX) United States $0.165B 0.00
Coherus BioSciences (CHRS) United States $0.161B 0.00
Checkpoint Therapeutics (CKPT) United States $0.161B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.160B 0.00
Sutro Biopharma (STRO) United States $0.159B 0.00
Solid Biosciences (SLDB) United States $0.156B 0.00
Actuate Therapeutics (ACTU) United States $0.155B 0.00
Innate Pharma S.A (IPHA) France $0.155B 0.00
Greenwich LifeSciences (GLSI) United States $0.154B 0.00
Zura Bio (ZURA) United States $0.153B 0.00
Puma Biotechnology (PBYI) United States $0.153B 6.50
2seventy Bio (TSVT) United States $0.153B 0.00
Caribou Biosciences (CRBU) United States $0.152B 0.00
Ventyx Biosciences (VTYX) United States $0.151B 0.00
Compugen (CGEN) Israel $0.147B 82.50
InflaRx (IFRX) Germany $0.147B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Aligos Therapeutics (ALGS) United States $0.143B 0.00
Instil Bio (TIL) United States $0.141B 0.00
Climb Bio (CLYM) United States $0.139B 0.00
Sagimet Biosciences (SGMT) United States $0.138B 0.00
Seer (SEER) United States $0.137B 0.00
Biomea Fusion (BMEA) United States $0.134B 0.00
X4 Pharmaceuticals (XFOR) United States $0.128B 0.00
XBiotech (XBIT) United States $0.127B 0.00
Leap Therapeutics (LPTX) United States $0.123B 0.00
PepGen (PEPG) United States $0.123B 0.00
Renovaro (RENB) United States $0.121B 0.00
Black Diamond Therapeutics (BDTX) United States $0.121B 0.00
Akoya Biosciences (AKYA) United States $0.120B 0.00
Alto Neuroscience (ANRO) United States $0.118B 0.00
Elutia (ELUT) United States $0.118B 0.00
Monopar Therapeutics (MNPR) United States $0.117B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.116B 0.00
Cabaletta Bio (CABA) United States $0.114B 0.00
TELA Bio (TELA) United States $0.113B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
Inventiva S.A (IVA) France $0.112B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.111B 0.00
Allakos (ALLK) United States $0.111B 0.00
INmune Bio (INMB) United States $0.109B 0.00
Editas Medicine (EDIT) United States $0.108B 0.00
Applied Therapeutics (APLT) United States $0.105B 0.00
MediciNova (MNOV) United States $0.104B 0.00
Nuvectis Pharma (NVCT) United States $0.104B 0.00
HilleVax (HLVX) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.101B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Adverum Biotechnologies (ADVM) United States $0.100B 0.00
CAMP4 Therapeutics (CAMP) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
23andMe Holding (ME) United States $0.093B 0.00
Invizyne Technologies (IZTC) United States $0.093B 0.00
VistaGen Therapeutics (VTGN) United States $0.092B 0.00
Immunic (IMUX) United States $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Adlai Nortye (ANL) Cayman Islands $0.090B 0.00
Alpha Cognition (ACOG) Canada $0.088B 0.00
Skye Bioscience (SKYE) United States $0.086B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
Citius Oncology (CTOR) United States $0.085B 0.00
Theratechnologies (THTX) Canada $0.085B 0.00
Bluebird Bio (BLUE) United States $0.084B 0.00
Scilex Holding (SCLX) United States $0.084B 0.00
Rani Therapeutics Holdings (RANI) United States $0.084B 0.00
Genelux (GNLX) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 6.24
Genenta Science S.p.A (GNTA) Italy $0.083B 0.00
Quince Therapeutics (QNCX) United States $0.083B 0.00
ALX Oncology Holdings (ALXO) United States $0.082B 0.00
Atara Biotherapeutics (ATRA) United States $0.082B 0.00
Abpro Holdings (ABP) United States $0.081B 0.00
Entera Bio (ENTX) Israel $0.081B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.078B 0.00
Aadi Bioscience (AADI) United States $0.077B 0.00
Vor Biopharma (VOR) $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Generation Bio (GBIO) United States $0.074B 0.00
I-Mab (IMAB) China $0.074B 0.00
Agenus (AGEN) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Vigil Neuroscience (VIGL) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.072B 0.00
Annovis Bio (ANVS) United States $0.071B 0.00
FibroBiologics (FBLG) United States $0.070B 0.00
Werewolf Therapeutics (HOWL) United States $0.070B 0.00
Cue Biopharma (CUE) United States $0.069B 0.00
Immuneering (IMRX) United States $0.069B 0.00
Ovid Therapeutics (OVID) United States $0.068B 0.00
Connect Biopharma Holdings (CNTB) United States $0.067B 0.00
DBV Technologies S.A (DBVT) France $0.067B 0.00
PDS Biotechnology (PDSB) United States $0.065B 0.00
BGM Group (BGM) China $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
BeyondSpring (BYSI) United States $0.062B 0.00
IO Biotech (IOBT) Denmark $0.061B 0.00
Boundless Bio (BOLD) United States $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Spero Therapeutics (SPRO) United States $0.059B 15.43
Kronos Bio (KRON) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Shattuck Labs (STTK) United States $0.058B 0.00
Invivyd (IVVD) United States $0.057B 0.00
Rapt Therapeutics (RAPT) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Oncobiologics (OTLK) United States $0.051B 0.00
Passage Bio (PASG) United States $0.051B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.050B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
Clene (CLNN) United States $0.045B 0.00
CalciMedica (CALC) United States $0.044B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.044B 0.00
Omega Therapeutics (OMGA) United States $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Q32 Bio (QTTB) United States $0.042B 0.00
AN2 Therapeutics (ANTX) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.040B 0.00
MiNK Therapeutics (INKT) United States $0.040B 0.00
Opus Genetics (IRD) United States $0.040B 0.00
Exicure (XCUR) United States $0.040B 0.00
Rallybio (RLYB) United States $0.039B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Enzo Biochem (ENZ) United States $0.038B 0.00
Forte Biosciences (FBRX) United States $0.037B 0.00
Precision BioSciences (DTIL) United States $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Lantern Pharma (LTRN) United States $0.036B 0.00
KALA BIO (KALA) United States $0.036B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.035B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
LakeShore Biopharma (LSB) China $0.034B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.031B 0.00
Cognition Therapeutics (CGTX) United States $0.030B 0.00
Lisata Therapeutics (LSTA) United States $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
OnKure Therapeutics (OKUR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Cadrenal Therapeutics (CVKD) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Medicus Pharma (MDCX) Canada $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Intensity Therapeutics (INTS) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Beyond Air (XAIR) United States $0.026B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Cara Therapeutics (CARA) United States $0.024B 0.00
NKGen Biotech (NKGN) United States $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Cocrystal Pharma (COCP) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Gelteq (GELS) Australia $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
Affimed (AFMD) Germany $0.022B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Ocean Biomedical (OCEA) United States $0.021B 0.00
IN8bio (INAB) United States $0.020B 0.00
BioXcel Therapeutics (BTAI) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
MetaVia (MTVA) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
HCW Biologics (HCWB) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Cingulate (CING) United States $0.016B 0.00
Palvella Therapeutics (PVLA) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Imunon (IMNN) United States $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
Carmell (CTCX) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Eyenovia (EYEN) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Apollomics (APLM) United States $0.012B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Vincerx Pharma (VINC) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Polyrizon (PLRZ) Israel $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
GRI Bio (GRI) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Soligenix (SNGX) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00